Milk-derived protein functions as a longevity promoter: Lactoferrin, derived from milk-derived products, slows down cardiac aging, and increases lifespan, via up-regulation of BubR1 and others genes, 21/March/2019, 8.35 am

Hydrogen gas-based regenerative stem cell therapy  for Myocardial Infarction:  Subcutaneous  injection of hydrogen  gas  inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of its target gene, 21/March/2019, 12.06 am
March 20, 2019
Molecular therapy for diabetes (TIDM): Nifedipine (trade names: Adalat and others), a drug used in the treatment of angina, and high blood pressure, increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 21/March/2019, 8.40 am
March 21, 2019
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston, USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Milk-derived protein functions as a longevity promoter: Lactoferrin, derived from milk-derived products, slows down cardiac aging, and increases lifespan, via up-regulation of BubR1 and others genes

 


From research findings to Therapeutic Opportunity: 

This study suggests, for the first time, that Lactoferrinby increasing the expression of its target gene, may: (a) increase the expression of BuBR1 (BUB1 Mitotic Checkpoint Serine/Threonine Kinase); (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (fig. 1).

Figure 1. Lactoferrin  functions as a longevity promoter.  Lactoferrin may extend  mammalian lifespan, via up-regulation of BuBR1; and down-regulation of p70 S6 Kinase

Figure 2. Lactoferrin functions as a longevity-promoter through induction of BuBR1.

Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median lifespan. Thus, Lactoferrin or its analogs, either alone or in combination with other drugs, may be used to extend the lifespan of an individual (fig.2).

[easy_payment currency=”USD”]


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by Dr L Boominathan Ph.D.

Amount: $750#

Undisclosed mechanistic information: How Lactoferrin  increases the expression of BubR1 and extend mammalian life-span

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation

For purchase and payment details, you may reach us at admin@genomediscovery.org


References

Web: http://genomediscovery.org or http://newbioideas.com

CitationBoominathan, L., Milk-derived protein functions as a longevity promoter: Lactoferrin, derived from milk-derived products, slows down cardiac aging, and increases lifespan, via up-regulation of BubR1 and others genes, 21/March/2019, 8.35 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

 

 

Comments are closed.